Business Wire

Galeria Teams Up With Blue Yonder to Enhance the In-Store and Online Customer Shopping Experience

13.5.2025 10:00:00 CEST | Business Wire | Press Release

Share

In today's rapidly evolving retail landscape, consumers increasingly seek personalized shopping experiences tailored to meet their specific demand requirements. For omni-channel retailers, success depends on seamlessly delivering high-quality products and excellent customer service powered by advanced technology that effectively supports a demand-driven, omni-channel strategy.

That is why Galeria, Germany´s leading department store chain, has chosen to deploy Blue Yonder’s demand and replenishment capabilities to strengthen its supply chain and enhance operational efficiency. This strategic investment enables the retailer to deliver a highly responsive and seamless shopping experience across both in-store and online channels, reinforcing Galeria's commitment to quality and convenience.

Galeria previously relied mainly on manual processes that limited the company’s ability to forecast demand and accurately allocate inventory across its stores. Through strong collaboration between Galeria's IT, purchasing and supply chain teams and Blue Yonder, the teams were able to significantly improve the retailer’s data quality, availability, and business process efficiency. The collaboration was also pivotal in establishing well-defined system interfaces to support seamless data integration and automation. A crucial milestone in this transformation was the development of a robust forecasting model, built through extensive analysis of transactional and promotional data.

"Galeria's supply chain management is undergoing a significant transformation, with a primary focus on boosting customer satisfaction,” said Moritz Winter, chief supply chain officer, Galeria. “To achieve this, it was crucial to enhance both stock availability and allocation accuracy. There was an urgent need to improve the management of allocations and replenishments, streamline business processes, and implement standardization and automation. Galeria recognized Blue Yonder as the ideal supply chain solutions provider for this transformation.”

"Blue Yonder’s demand and replenishment capabilities provide a high level of standardization, AI-driven forecasting, and process simplification, making them a perfect fit for our needs,” said Alexander Rings, director, inventory management & buying analytics, Galeria. “The implementation was initially designed to help us transform into a customer- and demand-driven supply chain by leveraging software as an enabler; however, it also reshaped our understanding of central business processes and needs. While stock availability increased significantly, we are in parallel working on fundamentally improving data and buying processes."

With Blue Yonder’s AI-powered demand and replenishment capabilities, Galeria will be able to:

  • Utilize a fully automated machine learning model that enhances supply chain agility and resilience, allowing rapid adaptation to local demand, market shifts, and external factors.
  • Improve customer service levels by aligning inventory with actual demand, reducing the risk of stockouts, minimizing overstocking, and reducing waste.
  • Streamline lifecycle management, especially for seasonal and promotional products.
  • Accelerate new product introductions and optimize seasonal assortment plans.
  • Enhance end-of-life product management, reducingmarkdowns and excess inventory through demand pattern analysis.

With Blue Yonder’s capabilities now live, Galeria can forecast, plan, and execute with greater accuracy – optimizing inventory, improving fulfillment, and driving operational efficiency across both in-store and online channels. This transformation not only strengthens Galeria’s supply chain but also deepens customer loyalty through a seamless shopping experience.

“We are proud to collaborate with Galeria to optimize their supply chain. As Galeria continues its business and processes innovation, we look forward to being a key solution provider and advisor in their journey, ensuring that their supply chain evolves alongside their success," said Vince Beacom, president, global retail, Blue Yonder.

Additional Resources:

About Galeria

With around 185 million visitors a year and 83 stores in around 70 cities, GALERIA S.à r.l. & Co. KG, the largest department store in Germany, always has one goal in mind: to focus on its customers. Versatility, regionality and strategic partnerships play a decisive role in this. A mix of modern brands, paired with quality and first-class service, characterize the innovative and inspiring shopping experience. GALERIA analyzes its target groups precisely and is therefore the market leader in categories such as lingerie, luggage and accessories. The market halls and restaurants round off the shopping offer in the department stores. In addition to the stationary range, GALERIA offers around 1,500 brands on its online marketplace, www.galeria.de. All this makes GALERIA one of the most important shopping destinations in the heart of German city centers. More information at www.galeria.de.

About Blue Yonder

Blue Yonder is the world leader in end-to-end digital supply chain transformation. With a unified, AI-driven platform and multi-tier network, Blue Yonder empowers businesses to operate sustainably, scale profitably, and delight their customers — all at machine speed. Blue Yonder’s modern supply chain innovations and unmatched industry expertise help more than 3,000 retailers, manufacturers, and logistics service providers to confidently navigate supply chain complexity and disruption. blueyonder.com

Blue Yonder” is a trademark or registered trademark of Blue Yonder Group, Inc. Any trade, product or service name referenced in this document using the name “Blue Yonder” is a trademark and/or property of Blue Yonder Group, Inc. All other company and product names may be trademarks, registered trademarks or service marks of the companies with which they are associated.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250513357648/en/

Contacts

Blue Yonder Corporate Communications:
mediarelationsteam@blueyonder.com
U.S.: +1 480-308-3037
EMEA: +39 335 7849149

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press Release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press Release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press Release

Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press Release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press Release

Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye